Inflammatory Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-17Clinical Trial Update: Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
A Phase 2 trial evaluating Rituximab for chronic inflammatory demyelinating polyneuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-18Clinical Trial Update: Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) [Phase 4]
Phase 4 trial evaluating alemtuzumab for Chronic Inflammatory Demyelinating Polyneuropathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-18Clinical Trial Update: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy [Phase 2]
A Phase 2 pilot study of Acthar Gel for chronic inflammatory demyelinating polyneuropathy has been withdrawn.